{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:45:36Z","timestamp":1792601136377,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.urolonc.2020.05.024","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T00:31:16Z","timestamp":1592699476000},"page":"846.e9-846.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer"],"prefix":"10.1016","volume":"38","author":[{"given":"Erica","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei S.","family":"Purysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.05.024_bib0001","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0002","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0003","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cncr.31051","article-title":"Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance\/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy","volume":"124","author":"Truong","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.euf.2018.05.005","article-title":"Predicting benign prostate pathology on magnetic resonance imaging\/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy: external validation of a prognostic nomogram","volume":"5","author":"Bjurlin","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0006","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1148\/radiol.2019182946","article-title":"PI-RADS Steering Committee: The PI-RADS multiparametric MRI and MRI-directed biopsy pathway","volume":"292","author":"Padhani","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0007","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.eururo.2017.02.026","article-title":"What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel","volume":"72","author":"Moldovan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS Version 2 lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0009","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000365697","article-title":"mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 lesions","volume":"8","author":"Liddell","year":"2015","journal-title":"Curr Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0011","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.juro.2017.03.131","article-title":"Prospective evaluation of PI-RADS Version 2 using the International Society of Urological Pathology Prostate Cancer Grade Group system","volume":"198","author":"Mehralivand","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0012","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.urology.2018.12.010","article-title":"Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy","volume":"126","author":"Bhat","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bju.13711","article-title":"Multicentre evaluation of target and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy","volume":"120","author":"Hansen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients","volume":"119","author":"Washino","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0016","article-title":"Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer","author":"Venderink","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/bju.12639","article-title":"Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies","volume":"115","author":"Rais-Bahrami","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-na\u00efve men","volume":"2","author":"Boesen","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0019","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1007\/s00330-019-06114-x","article-title":"Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings","volume":"29","author":"Purysko","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.urolonc.2020.05.024_bib0021","series-title":"R: A language and environment for statistical computing","year":"2019"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920302490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920302490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:49Z","timestamp":1761041989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920302490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1078143920302490"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.024","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}